Trevi Therapeutics Inc (TRVI) — Financial Flexibility Index
Trevi Therapeutics Inc (TRVI) has a Financial Flexibility Index of -2.22x as of March 2026. Free cash flow of $-16.59 Million (operating CF $-16.69 Million minus capex $102.00K) represents -2% of total liabilities ($7.48 Million). Check how strategically is Trevi Therapeutics Inc's equity deployed to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Trevi Therapeutics Inc Financial Flexibility Index (2016–2025)
Historical Financial Flexibility Index trend for Trevi Therapeutics Inc across 10 annual periods. See Trevi Therapeutics Inc short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Trevi Therapeutics Inc (2016–2025)
Year-by-year free cash flow to debt coverage for Trevi Therapeutics Inc. For the full company profile including market capitalisation, see Trevi Therapeutics Inc (TRVI) market capitalisation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -4.13x | $-42.08 Million | $-42.09 Million | $10.20 Million | ▼ -21.5% |
| 2024 | -3.40x | $-38.22 Million | $-38.26 Million | $11.26 Million | ▲ +26.3% |
| 2023 | -4.61x | $-31.57 Million | $-31.71 Million | $6.86 Million | ▼ -155.7% |
| 2022 | -1.80x | $-28.02 Million | $-28.18 Million | $15.56 Million | ▼ -33.9% |
| 2021 | -1.35x | $-28.79 Million | $-28.95 Million | $21.40 Million | ▲ +7.8% |
| 2020 | -1.46x | $-28.97 Million | $-29.00 Million | $19.85 Million | ▲ +65.5% |
| 2019 | -4.23x | $-23.08 Million | $-23.09 Million | $5.46 Million | ▲ +25.8% |
| 2018 | -5.70x | $-18.13 Million | $-18.29 Million | $3.18 Million | ▼ -433.2% |
| 2017 | -1.07x | $-7.96 Million | $-7.97 Million | $7.45 Million | ▼ -146.8% |
| 2016 | -0.43x | $-11.18 Million | $-11.19 Million | $25.82 Million | — |